Figures computed from official regulatory filings — .
Analysttarget 2.5 USD (+56%)
Ownershipinsiders 33.17% · institutions 11.49% · short 12.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Celularity Inc only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating multiple sclerosis, rheumatoid arthritis, stroke, and diabetic peripheral neuropathy. The company also produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
7 buys2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Barach Philip Alan | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Philip Alan | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Philip & Daniele Barach Family Trust | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Philip & Daniele Barach Family Trust | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Philip & Daniele Barach Family Trust | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Philip Alan | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Philip & Daniele Barach Family Trust | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Philip & Daniele Barach Family Trust | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Philip Alan | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Daniele Wolf | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Daniele Wolf | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Daniele Wolf | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Philip Alan | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Daniele Wolf | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Daniele Wolf | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Philip & Daniele Barach Family Trust | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Philip Alan | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Daniele Wolf | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Philip & Daniele Barach Family Trust | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Philip Alan | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barach Daniele Wolf | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Hariri Robert Jtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Brigido Stephen | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Brigido Stephen | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hariri Robert Jtrack record | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |